Home » Topics » BioWorld Science

BioWorld Science
RSS

TGF-beta decoy receptors patented by Tessa Therapeutics

Aug. 29, 2018

Biogen describes new mitogen-activated protein kinase kinase kinase 5 inhibitors

Aug. 29, 2018

GT Biopharma initiates OXS-1550 combination study with a multi billion dollar oncology drug

Aug. 29, 2018

Potential new anti-obesity target identified

Aug. 29, 2018

Sunitinib noninferior to nephrectomy in patients with metastatic renal-cell carcinoma

Aug. 29, 2018

Dissemination of data from four phase I studies GSK-2838232, a second-generation drug for HIV

Aug. 29, 2018

Preclinical identification of a potential druggable target for chronic kidney disease

Aug. 29, 2018

Release of safety and efficacy data of pinometostat for the treatment of acute advanced leukemia

Aug. 29, 2018

Early diagnosis of gestational diabetes

Aug. 29, 2018

Autoantibodies contribute to memory dysfunction

Aug. 29, 2018

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...